These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 9103344)

  • 1. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism.
    Carswell JM; Gordon JH; Popovsky E; Hale A; Brown RS
    J Clin Endocrinol Metab; 2013 Feb; 98(2):610-7. PubMed ID: 23264396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of Levothyroxine Bioequivalence Evaluation: Analysis of An Attempted Study.
    Mayor GH; Orlando T; Kurtz NM
    Am J Ther; 1995 Jun; 2(6):417-432. PubMed ID: 11850687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence studies for levothyroxine.
    Bolton S
    AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate.
    Blakesley VA
    AAPS J; 2005 Mar; 7(1):E42-6. PubMed ID: 16146348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study in normal human volunteers to compare the rate and extent of levothyroxine absorption from Synthroid and Levoxine.
    Berg JA; Mayor GH
    J Clin Pharmacol; 1992 Dec; 32(12):1135-40. PubMed ID: 1487553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic levothyroxine compared with synthroid in young children with congenital hypothyroidism.
    Lomenick JP; Wang L; Ampah SB; Saville BR; Greenwald FI
    J Clin Endocrinol Metab; 2013 Feb; 98(2):653-8. PubMed ID: 23293325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.
    Benvenga S; Carlé A
    Adv Ther; 2019 Sep; 36(Suppl 2):59-71. PubMed ID: 31485974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
    Koytchev R; Lauschner R
    Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.
    Bunevicius R; Kazanavicius G; Zalinkevicius R; Prange AJ
    N Engl J Med; 1999 Feb; 340(6):424-9. PubMed ID: 9971866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutical comparison of two levothyroxine sodium products.
    Blouin RA; Clifton GD; Adams MA; Foster TS; Flueck J
    Clin Pharm; 1989 Aug; 8(8):588-92. PubMed ID: 2504532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of levothyroxine tablets administered to a target population in steady state.
    Cerutti R; Rivolta G; Cavalieri L; Di Giulio C; Grossi E; Vago T; Baldi G; Righini V; Marzo A
    Pharmacol Res; 1999 Mar; 39(3):193-201. PubMed ID: 10094844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of therapeutic failure associated with levothyroxine brand interchange.
    Copeland PM
    Ann Pharmacother; 1995 May; 29(5):482-5. PubMed ID: 7655130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of brand name and generic levothyroxine.
    Stoffer SS; Szpunar WE
    JAMA; 1980 Oct; 244(15):1704-5. PubMed ID: 7411829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
    Ain KB; Pucino F; Shiver TM; Banks SM
    Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of interchangeability of two brands of levothyroxine preparations with a third-generation TSH assay.
    Escalante DA; Arem N; Arem R
    Am J Med; 1995 Apr; 98(4):374-8. PubMed ID: 7709950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levothyroxine bioequivalence.
    Schellhase KG; Ellsworth A
    J Fam Pract; 1997 Jul; 45(1):23-4. PubMed ID: 9228909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.